Seif El-Din Z, Afify M, Zayed E, Elsabaawy D, Tharwa ES, Elsharawy A, Abdelsameea E, Rady MA. Dapagliflozin as an oral antihyperglycemic agent in the management of diabetes mellitus in patients with liver cirrhosis. World J Exp Med 2024; 14(4): 95272 [PMID: 39713077 DOI: 10.5493/wjem.v14.i4.95272]
Abdallah Al Ghnaimat, Nour Aldin T. Ahmed, Omar Mahmood AL-AZZAWI, EzzElDien A. Ibrahim, Roaa Rayyan, Souheb Alkloub, Ekram Al Joufi, Ezz Eldein Breish, Sana Shaik, Noorhan Al-Kadhimi, Batool Al Masalha, Hossam Abdelbaqi, Dalia Atef Abouda, Dirk Uhlmann. SGLT‐2 Inhibitors for Ascites Management in Liver Cirrhosis: A Systematic Review and Meta‐Analysis of Available Evidence. International Journal of Hepatology 2026; 2026(1)doi: 10.1155/ijh/7257876